scholarly journals 148P Phase III study of everolimus or placebo in addition to adjuvant hormone therapy for high risk early breast cancer: Subgroup analysis of the UCBG UNIRAD trial

2021 ◽  
Vol 32 ◽  
pp. S425
Author(s):  
P.H. Cottu ◽  
F. Dalenc ◽  
S. Chabaud ◽  
D. Allouache ◽  
D. Cameron ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Hormone Therapy ◽  
Early Breast Cancer ◽  
Subgroup Analysis ◽  
Phase Iii ◽  
Adjuvant Hormone Therapy ◽  
Breast Cancer Subgroup ◽  
Phase Iii Study

scholarly journals Identification of Subgroups of Early Breast Cancer Patients at High Risk of Nonadherence to Adjuvant Hormone Therapy: Results of an Italian Survey

2015 ◽  
Vol 15 (2) ◽  
pp. e131-e137 ◽  
Author(s):  
Nicola Tinari ◽  
Caterina Fanizza ◽  
Marilena Romero ◽  
Elisabetta Gambale ◽  
Luca Moscetti ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Hormone Therapy ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Breast Cancer Patients ◽  
Adjuvant Hormone Therapy ◽  
Italian Survey

Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2)

2021 ◽  
Vol 156 ◽  
pp. 138-148
Author(s):  
Volker Möbus ◽  
Hans-Joachim Lück ◽  
Ekkehart Ladda ◽  
Peter Klare ◽  
Marcus Schmidt ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Early Breast Cancer ◽  
Randomised Trial ◽  
Phase Iii ◽  
Dose Dense
Sign in / Sign up

Export Citation Format

Share Document